Liminal Biosciences Inc. (LMNL) Social Stream
Liminal BioSciences Inc (LMNL) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering LMNL.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-08-17 | 4 | $4.5 | $2.3 | $3.1 | $0.97 | 219.59% |
2022-03-21 | 2 | $2.3 | $2 | $2.15 | $0.97 | 121.65% |
The Trend in the Analyst Price Target
LMNL's average price target has moved down $0.62 over the prior 26 weeks.
Over the past 48 weeks, LMNL's average upside potential has been 86.67%.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2021-04-25 | 2 | 22.03809 | 2.70468 | 9.94036 | 4.00 | 148.51% |
2021-05-27 | 4 | 21.15995 | 2.69308 | 9.56980 | 4.23 | 126.24% |
2021-05-27 | 4 | 22.09544 | 2.81215 | 9.99288 | 4.23 | 136.24% |
2021-07-29 | 4 | 4.47770 | 2.28860 | 3.58318 | 2.94 | 21.88% |
2021-07-29 | 4 | 4.51771 | 2.30905 | 3.61519 | 2.94 | 22.97% |
LMNL Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
3 | 0 | 0 | 2 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
LMNL's average broker recommendation rating improved by 0 over the prior 30 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LMNL as an investment opportunity.
- Liminal BioSciences Inc's average analyst price target is greater than 4.07% of all US stocks.
- LMNL has a higher number of analysts covering the stock than 46.07% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, Liminal BioSciences Inc's variance in analysts' estimates is lower than -173.85% of them.
- In the context of stocks in the small market cap category, Liminal BioSciences Inc's upside potential (average analyst target price relative to current price) is greater than 274.39% of them.
In the Pharmaceutical Products industry, LIAN, LGVN, and LFVN are the three stocks most similar to Liminal BioSciences Inc regarding the price target and analyst recommendation information presented here.
Is LMNL a Buy, Hold or Sell? See the POWR Ratings now!